Gain Therapeutics, Inc. (GANX) vs SkinHealth Systems Inc. (SKIN)
A side-by-side comparison of Gain Therapeutics, Inc. and SkinHealth Systems Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GANX
Gain Therapeutics, Inc.
$1.69HealthcareDelayed quote: Oct 6, 2026, 2:48 PM EDT
SKIN
SkinHealth Systems Inc.
$0.58HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT
Total return — GANX vs SKIN
growth of $100 · dividends reinvested · last 6yGANX -84.9% (-27.0%/yr)SKIN -94.7% (-38.6%/yr)GANX compounded faster over this window
GANX SKIN
GANX vs SKIN: by the numbers
- •SKIN is the larger company ($76M vs $72M market cap).
- •Both run net losses; GANX's is the smaller (0.00% vs -9.79% net margin).
Metrics side by side
Valuation
| Metric | GANX | SKIN |
|---|---|---|
| P/S ratio | N/A | 0.26 |
| P/B ratio | 6.38 | 1.36 |
| EV / EBITDA | N/A | 10.30 |
| FCF yield | N/A | 22.02% |
Profitability
| Metric | GANX | SKIN |
|---|---|---|
| Gross margin | 0.00% | 66.34% |
| Operating margin | 0.00% | -1.49% |
| Net margin | 0.00% | -9.79% |
| ROE | -178.06% | -51.09% |
| ROIC | -159.24% | -1.02% |
Growth (annualized)
| Metric | GANX | SKIN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.24% |
| Total return CAGR (5Y) | -25.06% | -53.07% |
Frequently asked
- How have GANX and SKIN total returns compared?
- Over the past 5 years, GANX delivered -25.06% and SKIN delivered -53.07% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Gain Therapeutics ROESkinHealth Systems ROEGain Therapeutics operating marginSkinHealth Systems operating marginGain Therapeutics revenue growthSkinHealth Systems revenue growthGain Therapeutics free cash flowSkinHealth Systems free cash flow
Gain Therapeutics & SkinHealth Systems appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.